The Interaction between miRNAs and 14-3-3ζ Protein in Different Diseases

Ahmad Fazilat1, Alireza Soleimani Mamalo2, Salomeh Roshani3

  • 1Department of Genetics, Motamed Cancer Institute, Breast Cancer Research Center, ACECR, Tehran, Iran.

PubMed

Insights

MicroRNAs (miRNAs) regulate the 14-3-3ζ protein, influencing disease and cancer development. Understanding these interactions is crucial for disease prevention and treatment strategies.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • The 14-3-3 protein family regulates critical cellular processes like migration, angiogenesis, cell cycle, apoptosis, and signal transduction.
  • Dysregulation of the 14-3-3 protein family is implicated in disease and cancer development through various biological pathways.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by targeting messenger RNAs (mRNAs).

Purpose of the Study:

  • To investigate the intricate relationship between microRNAs (miRNAs) and the 14-3-3ζ protein.
  • To clarify the regulatory interactions between miRNAs and 14-3-3ζ.
  • To understand the role of these interactions in disease pathogenesis and potential prevention.

Main Methods:

  • Literature review focusing on molecular mechanisms of miRNA-mediated gene regulation.
  • Analysis of studies examining miRNA binding sites on 14-3-3ζ mRNA.
  • Review of experimental data demonstrating the impact of miRNA modulation on 14-3-3ζ expression and cellular functions.

Main Results:

  • miRNAs directly bind to 14-3-3ζ mRNA, leading to its inhibition or degradation.
  • Specific miRNAs have been identified as either inducers or suppressors of 14-3-3ζ expression.
  • Modulation of 14-3-3ζ by miRNAs affects cellular processes relevant to disease, including proliferation and apoptosis.

Conclusions:

  • miRNAs are key regulators of 14-3-3ζ, impacting cellular homeostasis.
  • The interplay between miRNAs and 14-3-3ζ represents a significant factor in the development or prevention of various diseases, including cancer.
  • Targeting miRNA-14-3-3ζ interactions may offer novel therapeutic strategies for disease management.